(Q37857246)

24 August 2017

1 reference

title

Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines (English)

1 reference

24 August 2017

1 reference

2

Ray Borrow

1 reference

24 August 2017

Jan Poolman

1

1 reference

24 August 2017

1 March 2011

1 reference

Expert Review of Vaccines

24 August 2017

1 reference

24 August 2017

10

1 reference

24 August 2017

3

1 reference

24 August 2017

307-322

1 reference

Bacterial meningitis in the United States in 1995. Active Surveillance Team

24 August 2017

1 reference

Burden of meningitis and other severe bacterial infections of children in africa: implications for prevention

21 January 2018

1 reference

Prospects for a vaccine against otitis media

21 January 2018

1 reference

Epidemiology and etiology of childhood pneumonia

21 January 2018

1 reference

The Role of Encapsulation and Host Age in the Clearance of Haemophilus influenzae Bacteremia

21 January 2018

1 reference

Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing.

21 January 2018

1 reference

Human Serum Activities against Hemophilus influenzae, Type b

21 January 2018

1 reference

Role of Immunity in the Clearance of Bacteremia Due to Haemophilus influenzae

21 January 2018

1 reference

Prevention of Haemophilus influenzae type b infections in high-risk infants treated with bacterial polysaccharide immune globulin

21 January 2018

1 reference

Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in Caucasian adults

21 January 2018

1 reference

Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine

21 January 2018

1 reference

Increased risk of hospitalization for acute lower respiratory tract infection among Australian indigenous infants 5-23 months of age following pneumococcal vaccination: a cohort study

21 January 2018

1 reference

Splenic macrophages: antigen presenting cells for T1-2 antigens

21 January 2018

1 reference

Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine

21 January 2018

1 reference

Neisseria meningitidis serogroup A vaccines: an overview

21 January 2018

1 reference

Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemic.

21 January 2018

1 reference

Difficulties in establishing a serological correlate of protection after immunization with Haemophilus influenzae conjugate vaccines

21 January 2018

1 reference

Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.

21 January 2018

1 reference

Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial

21 January 2018

1 reference

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.

21 January 2018

1 reference

Disparity in functional activity between serum anticapsular antibodies induced in adults by immunization with an investigational group A and C Neisseria meningitidis-diphtheria toxoid conjugate vaccine and by a polysaccharide vaccine

21 January 2018

1 reference

Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization.

21 January 2018

1 reference

Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial

21 January 2018

1 reference

Clinical relevance of lower Hib response in DTPa-based combination vaccines

21 January 2018

1 reference

Antibody responses of black children to Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein conjugate vaccine in relation to the Km(1) allotype

21 January 2018

1 reference

Role of immunoglobulin subclasses and specific antibody determinations in the evaluation of recurrent infection in children

21 January 2018

1 reference

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine

21 January 2018

1 reference

Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines

21 January 2018

1 reference

Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy

21 January 2018

1 reference

Reconsideration of the use of meningococcal polysaccharide vaccine

21 January 2018

1 reference

Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.

21 January 2018

1 reference

Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal disease

21 January 2018

1 reference

Immunogenetic analysis of the immune response to pneumococcal polysaccharide

21 January 2018

1 reference

Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

21 January 2018

1 reference

Pneumococcal polysaccharides interact with human dendritic cells

21 January 2018

1 reference

The biology of Haemophilus influenzae type b vaccination failure

21 January 2018

1 reference

Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.

21 January 2018

1 reference

Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine

21 January 2018

1 reference

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

21 January 2018

1 reference

Priming for immunologic memory in adults by meningococcal group C conjugate vaccination

21 January 2018

1 reference

Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants

21 January 2018

1 reference

Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

21 January 2018

1 reference

Serologic responses to ACYW135 polysaccharide meningococcal vaccine in Saudi children under 5 years of age.

21 January 2018

1 reference

Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children

21 January 2018

1 reference

Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults

21 January 2018

1 reference

Meningococcal disease and prevention at the Hajj.

21 January 2018

1 reference

Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination

21 January 2018

1 reference

Revaccination with the 23-valent pneumococcal polysaccharide vaccine in middle-aged and elderly persons previously treated for pneumonia

21 January 2018

1 reference

Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.

21 January 2018

1 reference

Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines

21 January 2018

1 reference

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

Pneumococcal conjugate vaccines: emerging clinical information and its implications

21 January 2018

1 reference

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

21 January 2018

1 reference

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory

21 January 2018

1 reference

A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants.

21 January 2018

1 reference

Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants

21 January 2018

1 reference

Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

21 January 2018

1 reference

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents

21 January 2018

1 reference

Pneumococcal serotype 3 otitis media, limited effect of polysaccharide conjugate immunisation and strain characteristics.

21 January 2018

1 reference

Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota

21 January 2018

1 reference

Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.

21 January 2018

1 reference

The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.

21 January 2018

1 reference

Meningococcal polysaccharide-protein conjugate vaccines.

21 January 2018

1 reference

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

21 January 2018

1 reference

Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans

21 January 2018

1 reference

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

21 January 2018

1 reference

Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.

21 January 2018

1 reference

Glycoconjugate vaccines and immune interference: A review

21 January 2018

1 reference

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

21 January 2018

1 reference

Tolerability and immunogenicity of an eleven valent mixed carrier Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid or tetanus protein conjugate vaccine in Finnish and Israeli infants

21 January 2018

1 reference

Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components

21 January 2018

1 reference

Antibody to Capsular Polysaccharides of Streptococcus pneumoniae: Prevalence, Persistence, and Response to Revaccination

21 January 2018

1 reference

Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

21 January 2018

1 reference

Pneumococcal antibodies in a child with type 14 pneumococcal conjugate vaccine failure

21 January 2018

1 reference

Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.11.8

1 reference

24 August 2017

1 reference

PubMed ID

21434799